Back to search
BRAF V600 Colorectal Cancer
Clinical trial pipeline · Data from ClinicalTrials.gov
See which BRAF V600 Colorectal Cancer trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which BRAF V600 Colorectal Cancer trials you may qualify forBDTX-4933-101 is a first-in-human, open-label, Phase 1/2 dose escalation, dose optimization and expansion study designed to evaluate the safety and tolerability…
The goal of this clinical trial is to learn if Iparomlimab and Tuvonralimab combined with bevacizumab and FOLFIRI (IB-FOLFIRI) is safe and effective in treating…
Previous studies have shown that BRAFV600E mutant mCRC patients have a shorter survival time than BRAF wild type mCRC patients. For Chinese patients, however, i…
This phase I trial studies the side effects and best dose of vemurafenib when given together with cetuximab and irinotecan hydrochloride in treating patients wi…
This clinical trial is looking at two drugs called dabrafenib and trametinib. Dabrafenib and trametinib are approved as standard of care treatment for adult pat…